Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Matterport Cancels First Quarter 2024 Conference Call Following Definitive Agreement to be Acquired by CoStar Group
-
45Drives Unveils 45HomeLab Mini PCs for Home and Enterprise Environments
-
Verizon receives 2024 ENERGY STAR Award for 12th consecutive year
-
Bank of Åland Plc: Managers' Transactions (Eurell)
-
Decisions of the Organisational Meeting of Harvia Plc’s Board of Directors
-
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
-
Decisions of the Annual General Meeting of Shareholders held on 26 April 2024
-
Invesco Ltd: Form 8.3 - Anglo American PLC Opening Position Disclosure
-
Carbon Streaming Provides Update on Rimba Raya Project
-
Park Street A/S announces results of annual general meeting 2024
-
CleanCore Solutions, Inc. Announces Pricing of Initial Public Offering and NYSE American Listing
-
Array Hosts U.S. Energy Secretary Granholm, New Mexico Senators to Break Ground on New Solar Manufacturing Facility
-
Decisions of Annual General Meeting of AS Harju Elekter Group
-
Blockchain & Digital Assets Virtual Investor Conference: Presentations Now Available for Online Viewing
-
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
-
IB Acquisition Corp. Announces Upcoming Automatic Unit Separation
-
QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results
-
VCI Global Announces Earnings Call and Business Update on April 30th, 2024
-
LiveOne (NASDAQ: LVO) Expands Pay-Per-View Lineup with “KnuckleMania IV”
-
Bannix Acquisition Corp. Receives Nasdaq Notification of Non-Compliance With Listing Rules
-
Exagen Inc. Announces Changes to the Board of Directors
-
Shorepower Wins Two State of California Grants totaling $100,000
-
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
-
Correction Sono Group N.V. Announces Ticker Symbol Update and New Leadership Team as It Prepares for Market Advancement
-
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
-
Zignaly Announces Cosmos-Based ZIGChain and $100M Ecosystem Fund Backed by DWF Labs
-
Building Investor Confidence: RROCKET Burns 50% of Its Supply for Long-Term Growth
-
Qifu Technology Releases 2023 ESG Report
-
KE Holdings Inc. Files Its Annual Report on Form 20-F
-
Kimo Inc.’s Tom Smith Featured on Stockhouse Media’s The Watchlist Interview
-
Norwood Financial Corp Holds Annual Meeting of Shareholders
-
Fobi AI Signs Two-Year Sponsorship Agreement With Canadian Equestrian Rider Kassidy Keith
-
Monster Beverage to Report Financial Results for 2024 First Quarter on May 2, 2024
-
First Hawaiian, Inc. Reports First Quarter 2024 Financial Results and Declares Dividend
-
Ackroo Looks to Appoint Chief Financial Officer
-
Star Group, L.P. to Host Fiscal 2024 Second Quarter Webcast and Conference Call May 2, 2024
-
Leading Education Entrepreneurs join Genius Group as New Shareholders
-
Gentex Reports First Quarter 2024 Financial Results
-
Verizon to award $25K crisis-response grant to Maryland Tough Baltimore Strong Key Bridge Fund
-
Sentrics and Montereau Senior Living Forge Strategic Partnership
-
Neurosurgery Customer from Germany Orders Nexstim NBS System 5
-
Saia Announces Upcoming Retirement of CFO Douglas Col
-
Fujifilm Introduces First-of-its-Kind Transducer for On-Pump Intracardiac Echocardiography Imaging (OPIE) for Septal Myectomy
-
Alliance Trust PLC - Net Asset Value
-
Form 8.3 - Mattioli Woods PLC
-
Form 8.3 - Lok’n Store Group PLC
-
Form 8.3 - Hipgnosis Songs Fund Ltd
-
Form 8.3 - GCP Asset Backed Income Fund Ltd
-
Wondra: Reshaping the Future Blueprint of Metaverse 2.0
-
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET

